Key Takeaways
- The EMA is seeking feedback on its proposal to introduce a platform for addressing gaps and research needs in regulatory science.
- Industry will be able to observe some meetings, and possibly play a more active role in the platform after the initial one-year pilot phase.
- The aim is to bring together academic researchers working in regulatory science with regulators to improve how medicines are evaluated.
The European Medicines Agency is proposing to create a platform to identify “new and recurring issues in medicines development.”
The platform will help advance and accelerate regulatory science research, address regulatory science research questions and increase the quality and impact of research to improve regulatory practices and medicines development,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?